A Phase II Study of Nab-paclitaxel and Gemcitabine, in Elderly Patients with Previously Untreated, Metastatic Pancreatic Adenocarcinoma
Phase of Trial: Phase II
Latest Information Update: 16 Jul 2017
At a glance
- Drugs Paclitaxel (Primary) ; Gemcitabine
- Indications Pancreatic cancer
- Focus Therapeutic Use
- 06 Jul 2017 Planned End Date changed from 1 Sep 2017 to 1 Jun 2018.
- 06 Jul 2017 Planned primary completion date changed from 1 Sep 2017 to 1 Jun 2018.
- 05 Mar 2015 New trial record